XNAS · CMND
+18.49% · +$1.08 · Vol 147.1K
Market closed · last close 4:00 PM ET · price as of 18:13:11 ET
Clearmind Medicine Inc. Common Shares

Clearmind Medicine Inc. Common Shares

$6.92
Card
Relationship Map

Follow $CMND

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $CMND by email

Veridion Score

BETALOW CONF · 4 of 6 factors measuredMethodology
Earnings absence reason unknown · Analyst data unavailable at compute time
CMND
Clearmind Medicine Inc. Common Shares
Wed Oct 7 · market closed · Markets closed · resumes Thu 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

46/ 100
Veridion Score
Middle range · LOW confidence · 4 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: LOW · 4 of 6 factors measured · Wed Oct 7 · market closed · Markets closed · resumes Thu 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CMND moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CMND catalysts
About Clearmind Medicine Inc. Common Shares
Listed since
2021
Employees
2
Country
US

Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$5.75
Day high
$6.70
Day low
$5.54
Previous close
$5.84
52W high
$3,424
-99.80% from high
52W low
$5.54
0% of range
Market cap
$3M
Beta
-0.31
Shares out
507.4K
Volume
147.1K
1.34× rel vol
Avg volume
109.4K
VWAP
$6.13
Price history computed in-house
1W
+20.84%
1M
-16.02%
3M
-57.39%
1Y
-99.78%
YTD
-95.22%
SMA 50 $10.67 · below
SMA 200 $63.15 · below
52W position 0%

CMND overview

Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file
Loading financial statements
Loading CMND Form 4 filings
Public disclosures

Congress activity in CMND

No receipt-qualified filings found.

Federal contracts

CMND contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CMND in this window.
Lobbying spend

CMND lobbying filings, year to date.

Registered lobbying filings matched to Clearmind Medicine Inc. Common Shares.

$320.0K
Refresh interval: 12hSource: LDA disclosure filings
Trade (domestic/foreign)Health IssuesHealth Issues Defense Alcohol and Drug Abuse Veterans
Filing
$80.0K
LEAR CORPORATION

MCLARTY INBOUND LLC

Jul 20, 2026
Filing
$80.0K
LEAR CORPORATION

MCLARTY INBOUND LLC

Apr 20, 2026
Filing
$80.0K
LEAR CORPORATION

MCLARTY INBOUND LLC

Jan 20, 2026
Loading news for CMND
Analyst ratings
Sovereign unlock shows live analyst consensus for CMND.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.